VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NKE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NKENIKE, Inc.
$38.59$57.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNKEFinancials

NIKE, Inc. (NKE) Income Statement

30Y historyFree accessUpdated daily

Revenue erosion persisted with FY2027Q1 sales of $11.2B down 4.3% year-over-year, while gross margin recovered only partially to 42.8% from a 40.2% trough, remaining well below the 45.4% recorded in 2025Q1.

Income StatementBalance SheetCash FlowRatios

NKE Income Statement

Annual statement

NKE Income Statement

NIKE, Inc. (NKE) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMMay'26May'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Sales/Revenue45.89B46.4B46.31B51.36B51.22B46.71B44.54B37.4B39.12B36.4B34.35B32.38B30.6B27.8B25.31B23.33B20.12B19.01B19.18B18.63B16.33B14.95B13.74B12.25B10.7B9.89B9.49B9B8.78B9.55B9.19B
Revenue Growth %-1.18%0.19%-9.84%0.28%9.65%4.88%19.08%-4.38%7.47%5.96%6.1%5.8%10.08%9.82%8.5%15.98%5.8%-0.85%2.95%14.09%9.17%8.84%12.13%14.55%8.13%4.26%5.49%2.49%-8.13%3.99%41.97%
Cost of Goods Sold26.13B26.49B26.52B28.48B28.93B25.23B24.58B21.16B21.64B20.44B19.04B17.41B16.53B15.35B14.28B13.18B10.91B10.21B10.57B10.24B9.17B8.37B7.62B7B6.31B6B5.78B5.18B5.26B5.83B5.33B
COGS % of Revenue-57.09%57.27%55.44%56.48%54.02%55.18%56.58%55.33%56.16%55.42%53.76%54.03%55.23%56.41%56.5%54.26%53.72%55.13%54.97%56.14%55.95%55.49%57.14%59.02%60.7%60.97%57.59%59.98%61.05%58.07%
Gross Profit19.77B19.91B19.79B22.89B22.29B21.48B19.96B16.24B17.47B15.96B15.31B14.97B14.07B12.45B11.03B10.15B9.2B8.8B8.6B8.39B7.16B6.59B6.12B5.25B4.38B3.89B3.7B3.81B3.51B3.72B3.85B
Gross Margin %43.07%42.91%42.73%44.56%43.52%45.98%44.82%43.42%44.67%43.84%44.58%46.24%45.97%44.77%43.59%43.5%45.74%46.28%44.87%45.03%43.86%44.05%44.51%42.86%40.98%39.3%39.03%42.41%40.02%38.95%41.93%
Gross Profit Growth %-0.61%-13.53%2.67%3.79%7.6%22.91%-7.06%9.51%4.21%2.28%6.43%13.02%12.8%8.73%10.28%4.57%2.27%2.59%17.13%8.71%7.71%16.45%19.81%12.73%4.98%-2.91%8.62%-5.61%-3.39%42.85%
Operating Expenses16.01B16.11B16.09B16.58B16.38B14.8B13.03B13.13B12.7B11.51B10.56B10.47B9.89B8.77B7.8B7.08B6.36B6.33B6.15B5.95B5.03B4.48B4.22B3.7B3.15B2.84B2.69B2.83B2.66B2.86B2.47B
OpEx % of Revenue-34.73%34.74%32.27%31.98%31.69%29.24%35.09%32.47%31.63%30.75%32.34%32.33%31.53%30.8%30.34%31.62%33.27%32.07%31.96%30.8%29.94%30.73%30.21%29.49%28.66%28.35%31.46%30.25%29.91%26.91%
Selling, General & Admin16.01B16.11B16.09B16.58B16.38B14.8B13.03B13.13B12.7B11.51B10.56B10.47B9.89B8.77B7.8B7.08B6.36B6.33B6.15B5.95B5.03B4.48B4.22B3.7B3.15B2.84B2.69B2.61B2.43B2.62B2.3B
SG&A % of Revenue-34.73%34.74%32.27%31.98%31.69%29.24%35.09%32.47%31.63%30.75%32.34%32.33%31.53%30.8%30.34%31.62%33.27%32.07%31.96%30.8%29.94%30.73%30.21%29.49%28.66%28.35%28.98%27.65%27.47%25.08%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses000000000000000000000000000223.6M228.8M233.5M168.3M
Operating Income3.76B3.8B3.7B6.31B5.92B6.67B6.94B3.12B4.77B4.45B4.75B4.5B4.17B3.68B3.24B3.07B2.84B2.47B2.45B2.43B2.13B2.11B1.89B1.55B1.23B1.05B1.01B984.9M856.8M863.8M1.38B
Operating Margin %8.2%8.19%7.99%12.29%11.55%14.29%15.58%8.33%12.2%12.21%13.83%13.91%13.64%13.24%12.79%13.15%14.12%13.01%12.8%13.07%13.06%14.1%13.78%12.65%11.49%10.64%10.69%10.95%9.76%9.04%15.02%
Operating Income Growth %-2.65%-41.34%6.69%-11.39%-3.78%122.7%-34.72%7.36%-6.4%5.49%7.83%13.45%13.65%5.51%8.03%14.83%0.78%0.87%14.16%1.07%11.38%22.2%26.06%16.8%3.78%2.97%14.95%-0.81%-37.4%41.47%
EBITDA4.52B4.55B4.51B7.16B6.77B7.51B7.73B4.23B5.49B5.22B5.46B5.16B4.82B4.27B3.74B3.46B3.2B2.87B2.84B2.76B2.4B2.4B2.18B1.86B1.49B1.32B1.23B1.21B1.09B1.1B1.55B
EBITDA Margin %9.85%9.8%9.74%13.93%13.23%16.09%17.36%11.32%14.04%14.34%15.91%15.95%15.76%15.35%14.77%14.85%15.9%15.09%14.8%14.79%14.71%16.05%15.88%15.21%13.95%13.38%12.94%13.44%12.37%11.49%16.85%
EBITDA Growth %6.6%0.82%-36.97%5.62%-9.86%-2.83%82.66%-22.91%5.23%-4.5%5.83%7.05%13.08%14.06%7.94%8.32%11.46%1.12%3.01%14.7%0.08%10.03%17.08%24.9%12.67%7.8%1.64%11.32%-1.07%-29.12%39.76%
D&A (Non-Cash Add-back)761M747M808M844M859M840M797M1.12B720M774M716M662M649M586M502M396M358M396M383.3M321.5M270.2M290.9M287.7M313.5M262.5M271.6M214.1M223.6M228.8M233.5M168.3M
EBIT3.8B3.8B4.17B6.96B6.48B6.94B6.94B3.12B4.77B4.45B4.75B4.5B4.17B3.68B3.24B3.07B2.84B2.47B2.45B2.43B2.13B2.11B1.89B1.55B1.23B1.05B1.01B984.9M856.8M863.8M1.38B
Net Interest Income-72M-50M115M169M14M-198M-255M-82M-42M-47M-55M-21M-33M-38M-2M-10M-10M-13.7M8M77.1M67.2M36.8M-4.8M-25M-28.8M-34M00000
Interest Income127M0404M430M297M94M34M62M82M70M27M12M6M5M4M27M30M30.1M48.2M115.8M116.9M87.3M34.9M014.1M13.6M00000
Interest Expense199M50M289M261M283M292M289M144M124M117M82M33M39M43M6M37M40M43.8M40.2M38.7M49.7M50.5M39.7M25M42.9M47.6M00000
Other Income/Expense138M100M183M389M286M-24M-276M-228M29M-120M137M121M30M-136M18M-58M21M43M-498.3M69.2M68.1M32.4M-33.9M-99.7M-106.3M-35.2M-92.8M-65.7M-110.7M-210.8M-84.6M
Pretax Income3.9B3.9B3.88B6.7B6.2B6.65B6.66B2.89B4.8B4.33B4.89B4.62B4.21B3.54B3.26B3.01B2.86B2.52B1.96B2.5B2.2B2.14B1.86B1.45B1.12B1.02B921.4M919.2M746.1M653M1.3B
Pretax Margin %8.5%8.41%8.39%13.04%12.11%14.24%14.96%7.72%12.27%11.88%14.22%14.28%13.74%12.75%12.86%12.91%14.23%13.24%10.2%13.44%13.47%14.32%13.54%11.83%10.5%10.28%9.71%10.22%8.5%6.84%14.1%
Income Tax806M792M666M1B1.13B605M934M348M772M2.39B646M863M932M851M805M754M690M610M469.8M619.5M708.4M749.6M648.2M504.4M382.9M349M331.7M340.1M294.7M253.4M499.4M
Effective Tax Rate %20.67%20.31%17.14%14.93%18.24%9.1%14.02%12.05%16.08%55.31%13.22%18.67%22.16%24.01%24.72%25.04%24.11%24.24%24.01%24.75%32.2%35%34.85%34.79%34.1%34.31%36%37%39.5%38.81%38.56%
Net Income3.09B3.11B3.22B5.7B5.07B6.05B5.73B2.54B4.03B1.93B4.24B3.76B3.27B2.69B2.47B2.21B2.13B1.91B1.49B1.88B1.49B1.39B1.21B945.6M474M663.3M589.7M579.1M451.4M399.6M795.8M
Net Margin %6.74%6.7%6.95%11.1%9.9%12.94%12.86%6.79%10.3%5.31%12.34%11.61%10.7%9.69%9.77%9.48%10.6%10.03%7.75%10.11%9.14%9.31%8.82%7.72%4.43%6.7%6.21%6.44%5.14%4.18%8.66%
Net Income Growth %6.84%-3.45%-43.53%12.43%-16.14%5.57%125.56%-36.98%108.43%-54.41%12.77%14.88%21.54%8.94%11.8%3.66%11.85%28.27%-21.06%26.28%7.15%14.89%28.13%99.49%-28.54%12.48%1.83%28.29%12.96%-49.79%43.85%
Net Income (Continuing)3.09B3.11B3.22B5.7B5.07B6.05B5.73B2.54B4.03B1.93B4.24B3.76B3.27B2.69B2.45B2.26B2.17B1.91B1.49B1.88B1.49B1.39B1.21B945.6M740.1M668.3M589.7M579.1M451.4M399.6M795.8M
Discontinued Operations0000000000000021M-46M-39M00000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)2.082.102.163.733.233.753.561.602.491.172.512.161.851.491.361.181.100.970.760.930.730.660.560.440.220.300.270.260.200.170.33
EPS Growth %7.18%-2.78%-42.09%15.48%-13.87%5.34%122.5%-35.74%112.82%-53.39%16.2%16.76%24.16%9.56%15.25%7.27%13.4%27.63%-18.28%27.4%10.61%17.86%27.27%100%-26.67%11.11%3.85%30%17.65%-48.48%37.5%
EPS (Basic)-2.102.173.763.273.833.641.632.551.192.562.211.901.521.381.211.120.980.770.950.740.670.580.450.220.310.270.260.200.170.34
Diluted Shares Outstanding1.48B1.48B1.49B1.53B1.57B1.61B1.61B1.59B1.62B1.66B1.69B1.74B1.77B1.81B1.83B1.88B1.94B1.98B1.96B2.02B2.04B2.11B2.16B2.16B2.14B2.18B2.18B2.24B2.3B2.37B2.38B
Basic Shares Outstanding1.48B1.48B1.48B1.52B1.55B1.58B1.57B1.56B1.58B1.62B1.66B1.7B1.72B1.77B1.79B1.84B1.9B1.94B1.94B1.98B2.02B2.07B2.1B2.11B2.12B2.14B2.16B2.21B2.27B2.32B2.31B
Dividend Payout Ratio-77.45%71.45%38.05%39.68%30.38%28.6%57.19%33.06%64.3%26.72%27.18%27.47%29.67%28.44%28%26.02%26.5%31.39%21.92%23.04%20.9%19.54%18.95%29.07%19.43%21.99%22.98%30.17%31.86%12.68%

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Structural margin compression amid revenue erosion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Revenue Erosion Persists Beyond Inventory Reset

According to recent quarterly filings, NKE's revenue has contracted from $12.6B in 2024Q4 to $11.2B in 2027Q1, with eight of the last ten quarters showing negative growth; the brief stabilization in 2026 has given way to renewed weakness.

The revenue trajectory suggests that the inventory-clearing headwinds that began around 2025 have not fully resolved into a durable recovery. The mid-2026 plateau (growth of +1.1% to +0.6%) implied the trough may have been forming, yet 2026Q4 and 2027Q1 returned to negative territory (-1.1% and -4.3%), which warrants further investigation into whether demand weakness extends beyond wholesale destocking into direct consumer softness. Compared to peers like On Holding (+24.2% growth) and Deckers (+9.8%), NKE's top line appears to be losing share rather than merely experiencing cyclical normalization, and this gap may indicate structural brand relevance challenges.

Gross Margin Compression Signals Pricing Power Erosion

As reported in financial statements, NKE's gross margin declined from 45.4% in 2025Q1 to 40.2% in 2026Q3 before a partial recovery to 42.8% in 2027Q1, placing it well below peers On Holding at 62.8% and Deckers at 57.7%.

The 250-500 basis point gross margin swings quarter-to-quarter suggest significant promotional activity, likely to defend share in a competitive athletic footwear market. The partial margin recovery in 2026Q4 to 49.2% may indicate temporary pricing discipline or mix improvement, but the subsequent drop back to 42.8% in 2027Q1 suggests it was not sustained. For an industrial-scale brand with NKE's cost structure, persistent sub-43% gross margins in the current environment appear to imply limited pricing power relative to higher-margin niche competitors, and investors should monitor whether margin normalization requires volume sacrifice.

Fixed SG&A Base Amplifies Operating Deterioration

Based on EDBL's reported figures, NKE's SG&A has remained remarkably flat at approximately $4.0B per quarter even as revenue declined from $12.6B to $11.2B, producing negative operating leverage that compressed operating margin from 12.3% to 7.9% over the period.

The rigidity of SG&A at roughly 35% of revenue across a period of top-line contraction suggests that cost-restructuring efforts have not kept pace with revenue erosion, and the operating deleverage visible here may indicate limited ability to cut expenses without impairing brand investment. The outlier quarter of 2025Q4 — operating margin of just 2.9% — appears to have been driven by gross margin weakness rather than an SG&A spike, which implies the margin problem is primarily demand-side rather than controllable overhead. Any near-term recovery in revenue should produce meaningful operating margin leverage, but the durability of that leverage depends on whether revenue stabilizes above $12B on a sustained basis.

Volatile EPS Reflects Unstable Operating Base

As reported in recent SEC filings, NKE's quarterly EPS has swung from $0.99 in 2024Q4 to $0.14 in 2025Q4, with diluted EPS declining over 25% year-over-year for three consecutive quarters before stabilizing at $0.48 in 2027Q1.

The extreme EPS volatility — particularly the $0.14 quarter where net income collapsed to $211M — suggests that reported earnings quality is highly sensitive to gross margin fluctuations, leaving very little cushion for further deterioration. Stock-based compensation of $158-194M per quarter represents roughly 2-3% of revenue, which is material but not the primary driver of earnings instability; the real issue appears to be that net margin has halved from 11.9% to 6.3% without any corresponding structural change in the cost base. The persistent gap between operating income and net income (ranging from $150M to $280M quarterly) appears consistent with interest expense and taxes, though the absence of detailed non-operating breakdowns means investors should monitor for any one-time items that may be inflating or deflating reported results.

Margin Recovery May Be Structural, Not Cyclical

The most serious analytical challenge to NKE's recovery narrative is that gross margin has failed to return to the 45%+ levels seen in 2024Q4 and 2025Q1, remaining capped near 40-43% even as revenue stabilizes, suggesting structural rather than temporary margin compression.

A short-seller would focus on the pattern that every apparent margin recovery — 2026Q4 at 49.2%, 2026Q2 at 43.6% — has been followed by immediate retracement, which may indicate that promotional intensity is now embedded in the pricing model rather than a transitional inventory effect. The competitive gap versus On Holding (62.8% gross margin, 26.9% ROIC) and Deckers (57.7% gross margin, 101.4% ROIC) appears to be widening rather than narrowing, and NKE's 2027Q1 revenue decline of -4.3% occurring alongside SG&A remaining at $3.9B suggests the brand may be losing share precisely when it needs to invest. If gross margins cannot structurally recover above 44% while revenue growth stays below low single digits, the implied scenario of permanently lower operating margins in the 7-9% range — versus a historical 10-12% — would represent a meaningful de-rating of the earnings base.

NKE — Frequently Asked Questions

Quick answers to the most common questions about buying NKE stock.

What was NIKE, Inc.'s (NKE) revenue in 2026?

For fiscal year 2026, NIKE, Inc. (NKE) reported total revenue of $46.40B. This represents a 405.1% increase compared to $9.19B in 1997.

Is NIKE, Inc. (NKE) profitable?

NIKE, Inc. (NKE) is profitable, generating $3.11B in net income for the fiscal year ending 2026 with a net profit margin of 6.7%.

What is NIKE, Inc.'s operating profit margin?

NIKE, Inc. (NKE) reported an operating income of $3.80B, resulting in an operating profit margin of 8.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is NIKE, Inc.'s gross profit and gross margin?

NIKE, Inc. (NKE) generated $19.91B in gross profit for the year, representing a gross profit margin of 42.9%. This demonstrates the company's core pricing power and production efficiency.